AMNEAL PHARMACEUTICALS LLC Amneal Pharmaceuticals LLC 2026 Term Loan is a security (CUSIP 03167DAS3) tracked across SEC portfolio filings. 42 registered fund positions totaling $98.5M via N-PORT as of 2026-05-31.
Showing 15 of 42 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Partners Group Private Equity Fund, LLC | Partners Group Private Equity Fund, LLC | $30.8M | 19.47% |
| BlackRock Floating Rate Income Portfolio | BlackRock Funds V | $8.9M | 35.93% |
| Senior Debt Portfolio | Senior Debt Portfolio | $8.7M | 18.63% |
| Floating-Rate Portfolio | Eaton Vance Floating Rate Portfolio/MA | $5.8M | 16.05% |
| NYLIM VP Floating Rate Portfolio | NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | $4.0M | 35.36% |
| Nuveen Floating Rate Income Fund | Nuveen Floating Rate Income Fund | $3.7M | 27.36% |
| T. Rowe Price Floating Rate Fund | T. ROWE PRICE FLOATING RATE FUND, INC. | $3.5M | 8.69% |
| Eaton Vance Floating-Rate ETF | Morgan Stanley ETF Trust | $2.8M | 22.05% |
| CALAMOS STRATEGIC TOTAL RETURN FUND | CALAMOS STRATEGIC TOTAL RETURN FUND | $2.3M | 6.63% |
| Calamos Aksia Alternative Credit & Income Fund | Calamos Aksia Alternative Credit & Income Fund | $2.1M | 19.10% |
| BlackRock Debt Strategies Fund, Inc. | BlackRock Debt Strategies Fund, Inc. | $2.0M | 32.72% |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | CALAMOS CONVERTIBLE & HIGH INCOME FUND | $2.0M | 19.10% |
| XAI Octagon Floating Rate & Alternative Income Trust | XAI OCTAGON FLOATING RATE & ALTERNATIVE INCOME TRUST | $1.9M | 56.76% |
| Eaton Vance Floating-Rate Income Trust | Eaton Vance Floating-Rate Income Trust | $1.8M | 56.90% |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | $1.8M | 18.18% |